Palavras-chave
Como Citar
Resumo
Kawasaki disease (KD) is a disease that causes inflammation in blood vessels and can lead to serious heart problems, such as aneurysms. It is important to identify the disease quickly so that preventative measures can be taken. The main symptoms include fever, red eyes, swollen and red tongue, redness and swelling of the hands and feet, and swollen lymph nodes. If you notice these symptoms, seek medical attention immediately. Coronary CT angiography is a very effective test for detecting the presence of aneurysms and other cardiac complications in KD. Treatment includes immunoglobulin and aspirin, which help reduce inflammation in the blood vessels and minimize the risk of serious heart problems. To ensure good heart health in the long term, it is important to have regular follow-up with a cardiologist and undergo additional tests, such as exercise test, to monitor the evolution of the disease. If diagnosed early, KD can be treated successfully and prevent serious complications.
Referências
Nakamura, Y., Yashiro, M., Uehara, R., & Oki, I. (2012). Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005–2006. The Journal of epidemiology, 22(3), 216-2
Onouchi, Y., Ozaki, K., Burns, J. C., Shimizu, C., Terai, M., Hamada, H., ... & Tanaka, T. (2008). A genome-wide association study identifies three new risk loci for Kawasaki disease. Nature genetics, 40(6), 543-549.
Newburger, J. W., Takahashi, M., Beiser, A. S., Burns, J. C., Bastian, J., Chung, K. J., ... & Fulton, D. R. (2004). A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. New England Journal of Medicine, 341(24), 1837-1841.
Kobayashi, T., Saji, T., Otani, T., Takeuchi, K., Nakamura, T., Arakawa, H., ... & Ishikawa, Y. (2010). Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. The Lancet, 379(9826), 1613-1620.
Rowley, A. H., Shulman, S. T., Mask, C. A., Finn, L. S., Terai, M., Baker, S. C., ... & Kaplan, S. L. (2000). IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis, 182(4), 1183-1191.
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., ... & Pahl, E. (2017). Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation, 135(17), e927-e999.
Burns, J. C., Glode, M. P., Clarke, S. H., & Wiggins, J. (1985). A pilot study of intravenous gamma globulin in Kawasaki syndrome. New England Journal of Medicine, 312(16), 1072-1076.
Tremoulet, A. H., Jain, S., Jaggi, P., Jimenez-Fernandez, S., Pancheri, J. M., Sun, X., ... & Burns, J. C. (2017). Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. The Lancet, 390(10111), 856-865.
Eleftheriou, D., Levin, M., Shingadia, D., Tulloh, R., Klein, N. J., Brogan, P. A., ... & Dillon, M. J. (2010). Management of Kawasaki disease. Archives of Disease in Childhood, 95(1), 74-81.
Dominguez, S. R., Anderson, M. S., & Glodé, M. P. (2015). Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease. The Pediatric Infectious Disease Journal, 34(7), 792-793.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Sergio Rodrigo Beraldo, Amy Talita Brezger Santos, Ana Clara Beraldo Muniz, Gabriela Maria Ribeiro de Oliveira, Isadora Azevedo Cardeliquio Cantarelli, José Carlos Boschi Neto, Julia de Oliveira Chagas, Hygor Sartorio Sant’Ana, Renan Lemos Ferreira Andrade Paiva, Sasha Barbosa da Costa Pimenta Duarte